drug
larotrectinib sulfate
Marketedupdated 3mo agoby Bayer HealthCare Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 21, 2029
~3.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (48)
- May 16, 2037method-of-use (U-4123)US 11337967
- May 16, 2037method-of-use (U-4123)US 11337967
- May 16, 2037method-of-use (U-4123)US 11337967
- May 16, 2037method-of-use (U-4124)US 11974998
- May 16, 2037method-of-use (U-4124)US 11974998
- May 16, 2037method-of-use (U-4124)US 11974998
- Apr 4, 2037method-of-use (U-2473)US 10045991
- Apr 4, 2037formulationUS 10137127
- Apr 4, 2037formulationUS 10668072
- Apr 4, 2037method-of-use (U-2471)US 11191766
- Apr 4, 2037method-of-use (U-2470)US 11484535
- Aug 15, 2036compositionUS 10799505
- Aug 15, 2036compositionUS 10799505
- Aug 15, 2036compositionUS 10799505
- Nov 16, 2035compositionUS 10172861
- Nov 16, 2035compositionUS 10172861
- Nov 16, 2035compositionUS 10172861
- Nov 16, 2035method-of-use (U-2470)US 10285993
- Nov 16, 2035method-of-use (U-2470)US 10285993
- Nov 16, 2035method-of-use (U-2987)US 10813936
- Nov 16, 2035method-of-use (U-2987)US 10813936
- Nov 16, 2035method-of-use (U-2471)US 9782414
- Nov 16, 2035method-of-use (U-2475)US 9782414
- Nov 16, 2035method-of-use (U-2475)US 9782414
- Dec 23, 2029compositionUS 85132633.4y
- Dec 23, 2029compositionUS 85132633.4y
- Dec 23, 2029compositionUS 85132633.4y
- Oct 21, 2029method-of-use (U-2472)US 100057833.2y
- Oct 21, 2029method-of-use (U-2472)US 100057833.2y
- Oct 21, 2029method-of-use (U-2472)US 100057833.2y
- Oct 21, 2029method-of-use (U-2474)US 100470973.2y
- Oct 21, 2029method-of-use (U-2474)US 100470973.2y
- Oct 21, 2029method-of-use (U-2474)US 100470973.2y
- Oct 21, 2029method-of-use (U-2470)US 107740853.2y
- Oct 21, 2029method-of-use (U-2470)US 107740853.2y
- Oct 21, 2029method-of-use (U-2470)US 107740853.2y
- Oct 21, 2029method-of-use (U-2469)US 88656983.2y
- Oct 21, 2029method-of-use (U-2469)US 88656983.2y
- Oct 21, 2029method-of-use (U-2469)US 88656983.2y
- Oct 21, 2029compositionUS 91270133.2y
- Oct 21, 2029compositionUS 91270133.2y
- Oct 21, 2029compositionUS 91270133.2y
- Oct 21, 2029method-of-use (U-2470)US 94471043.2y
- Oct 21, 2029method-of-use (U-2470)US 94471043.2y
- Oct 21, 2029method-of-use (U-2470)US 94471043.2y
- Oct 21, 2029method-of-use (U-2469)US 96767833.2y
- Oct 21, 2029method-of-use (U-2469)US 96767833.2y
- Oct 21, 2029method-of-use (U-2469)US 96767833.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that